aXichem AB (AXIC-A.ST) Research

aXichem AB is a biotechnology firm, established in 2007 and headquartered in Malmö, Sweden, that specializes in creating natural analogue compounds. The company offers aXivite, a capsaicin analogue solution designed for various dietary health applications. Another key product, aXiphen-bio, functions as a biological repellent, providing antifouling protection for marine vessels and installations, and managing pests in agriculture, forestry, and for safeguarding cable infrastructure both within buildings and underground. Additionally, aXiphen-feed is developed to boost the health of poultry, including chickens and hens, as well as swine, such as pigs and piglets.

Market snapshot

Symbol
AXIC-A.ST
Price
$1.30
Day change
+0.39%
Market cap
$88.0M
P/E ratio
-5.34x
52-week range
1.135-4.1
Sector
Basic Materials
Industry
Chemicals - Specialty
Next earnings
in 2 months

Peer companies

  • Svenska Aerogel Holding AB (publ) (AERO.ST)
  • Arctic Minerals AB (publ) (ARCT.ST)
  • EcoRub AB (publ) (ECO-B.ST)
  • Nexam Chemical Holding AB (publ) (NEXAM.ST)
  • OrganoClick AB (publ) (ORGC.ST)
  • Photocat A/S (PCAT.ST)
  • Recyctec Holding AB ser. B (RECY-B.ST)
  • Serstech AB (SERT.ST)

Open aXichem AB (AXIC-A.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.